- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.04. | OSHA's Evolving Approach to Workplace Violence Prevention in Healthcare | ||
| 20.04. | Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing | ||
| 19.04. | Is Shah Capital's Criticism of Novavax Fair? A Wall Street Analyst Weighs In | ||
| 19.04. | Obsidian, Galera Therapeutics Merger Comes With $350M Infusion for Cancer Drug Trials | ||
| 19.04. | Expanding the CJR Model Is a Logical Step in VBC, but Implementation Challenges Remain | ||
| 19.04. | How Team-Based and Virtual Nursing Models Are Redefining Care Delivery | ||
| 19.04. | Trust and AI Adoption in Medicine | ||
| 17.04. | Kailera's Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs | ||
| 17.04. | Your Doctors and Nurses Are Burned Out. Here's What They Need | ||
| 17.04. | Strengthening Social Security in a Changing World | ||
| 16.04. | Wisp, Visby Partner to Expand Access to At-Home STI Test | ||
| 16.04. | CMS' New 'App Store' Is Trying to Turn Interoperability Into a Digital Health Distribution System | ||
| 16.04. | Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease | ||
| 16.04. | The Key Biomarkers Changing How and When We Diagnose Alzheimer's Disease | ||
| 16.04. | The End of Incrementalism: Why Healthcare Innovation is Finally Reshaping the Model | ||
| 16.04. | New Bill Seeks to Lower Out-of-Pocket Drug Costs | ||
| 15.04. | Why Innovaccer Is Pouring $250M into Its Agentic AI Platform | ||
| 15.04. | Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors | ||
| 15.04. | From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables | ||
| 15.04. | The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through Breaks | ||
| 15.04. | Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft | ||
| 15.04. | Vida Health Teams Up with OURA to Provide More Personalized Metabolic Care | ||
| 15.04. | Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease | ||
| 14.04. | 5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here's Why. | ||
| 14.04. | Why Synthetic Data is the Antidote to Clinical Trials |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.